Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance
Metastatic breast cancer continues to present significant therapeutic challenges, necessitating ongoing exploration of innovative treatments. The use of antibody-drug conjugates (ADCs) represents an effective treatment strategy that combines the targeting capabilities of monoclonal antibodies with t...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
THE HEALTHBOOK COMPANY LTD.
2024-10-01
|
| Seri Bilgileri: | healthbook TIMES. Oncology Hematology |
| Online Erişim: | https://doi.org/10.36000/HBT.OH.2024.21.155 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|